According to the report??U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012??the diabetes diagnosis, treatment and drug delivery market is expected to surpass $17.87 billion by 2018.
Market growth is predicted to be boosted by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.
Companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan are market leaders, this report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.?View the report:??U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012?
Pharmaceutical-market-research.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. The site is powered by Report Buyer.
Other Press Releases from Pharmaceutical-Market-Research.com
> World arthritis therapeutics market to grow 7.2% to 2018 says new report
> Protein-based therapy market to hit $ 143.4 Billion by 2015 says new report
> World hepatitis C drugs market to grow 28% to 2015
> Orphan Disease Therapeutics in CNS Market to Grow 17.6% to 2017 Says New Report
> World biosensor market to grow by 9.6% to reach $16.8billion by 2018
View all posts by Pharmaceutical-Market-Research.com
This entry was posted in Healthcare, Pharmaceuticals and tagged biosensors. Bookmark the permalink.